Bristol-Meyers Squibb Looks to Academia for Assistance on Fibrosis R&D

Wednesday, July 15, 2015

Source: FierceBiotech

Bristol-Myers Squibb ($BMY) is teaming up with researchers at the Medical University of South Carolina to shed some light on the root causes of fibrotic disease, planning translational studies on a handful of ailments with hopes of spotlighting new treatments.

View All News »